Can I read PSMA Radioligand Therapy in Prostate Cancer: Where Are We and Where Are We Heading? on EtoBox?

PSMA Radioligand Therapy in Prostate Cancer: Where Are We and Where Are We Heading? by Ludmila Santiago Almeida; Elba Cristina Sá de Camargo Etchebehere; Irene García Megías; Adriana K. Calapaquí Terán; Boris Hadaschik; Patrick M. Colletti; Ken Herrmann; Francesco Giammarile; Roberto C. Delgado Bolton is a Medicine article available to read on EtoBox.

What is PSMA Radioligand Therapy in Prostate Cancer: Where Are We and Where Are We Heading? about?

## Abstract Diagnosis and treatment of prostate cancer are complex and very challenging, being a major health care burden. The efficacy of radioligand therapy with prostate-specific membrane antigen agents has been proven beneficial in certain clinical indications. In this review, we describe management of prostate cancer patients according to current guidelines, especially focusing on the available clinical evidence for prostate-specific membrane antigen radioligand therapy.

Who reads PSMA Radioligand Therapy in Prostate Cancer: Where Are We and Where Are We Heading??

Author

Ludmila Santiago Almeida; Elba Cristina Sá de Camargo Etchebehere; Irene García Megías; Adriana K. Calapaquí Terán; Boris Hadaschik; Patrick M. Colletti; Ken Herrmann; Francesco Giammarile; Roberto C. Delgado Bolton

Publisher

Ovid Technologies (Wolters Kluwer Health)

Published

2023

Language

EN

Field

Medicine (Health Sciences)